Presymptomatic diagnosis of Fabry's disease: a case report

Rasmus Bo Hasselbalch1, Per Lav Madsen2, Henning Bundgaard3

  • 1Department of Cardiology, Copenhagen University Hospital - Herlev-Gentofte Hospital, Herlev Ringvej 75, Herlev, 2730, Denmark. r.hasselbalch@gmail.com.

Insights

Fabry disease, a genetic disorder affecting the alpha-galactosidase A enzyme, can mimic hypertrophic cardiomyopathy. Early diagnosis through cascade screening is crucial for affected families.

Area of Science:

  • Genetics
  • Cardiology
  • Rare Diseases

Background:

  • Fabry disease is an X-linked genetic disorder caused by deficient alpha-galactosidase A enzyme activity.
  • Cardiac involvement, mimicking hypertrophic cardiomyopathy, is a significant clinical manifestation.
  • Early symptoms in males include neuropathic pain and GI issues, progressing to cardiac, renal, and CNS effects.

Observation:

  • A case of Fabry disease was diagnosed in a daughter of an 81-year-old woman with late-onset cardiac disease.
  • The proband presented with cardiac conduction disease and heart failure.

Findings:

  • This case highlights the importance of considering Fabry disease in elderly patients with cardiac hypertrophy.
  • Cascade screening of relatives is essential for identifying affected individuals, including asymptomatic female carriers.

Implications:

  • Accurate diagnosis of Fabry disease is critical for timely enzyme replacement therapy and management.
  • Identifying Fabry disease in elderly patients prompts cascade screening, potentially revealing the disorder in younger family members.
  • Physicians should consider Fabry disease as a differential diagnosis in inherited cardiomyopathies, regardless of patient age.
Abstract